Related Experiment Video
Updated: Mar 13, 2026

Basophil Activation Test for Allergy Diagnosis
Published on: May 31, 2021
[Insect venom allergies : Update 2016 for otorhinolaryngologists]
L Klimek1,2, N Dippold3, A Sperl3
1Zentrum für Rhinologie und Allergologie, An den Quellen 10, 65183, Wiesbaden, Deutschland. ludger.klimek@Allergiezentrum.org.
Hymenoptera venom allergies are increasing. Molecular diagnostics and rush allergen-specific immunotherapy (AIT) improve diagnosis and treatment for these potentially life-threatening insect sting allergies.
Area of Science:
- Allergy and Immunology
- Otolaryngology
Background:
- Hymenoptera venom allergies are rising, posing significant health risks.
- Otolaryngologists require updated knowledge on diagnosing and treating these allergies.
Purpose of the Study:
- To outline modern diagnostic and treatment standards for Hymenoptera venom allergies.
- To emphasize the role of molecular diagnostics and specific immunotherapy.
Main Methods:
- Utilizing molecular diagnostics with recombinant allergens for precise diagnosis.
- Evaluating patient history and diagnostic tests to guide treatment.
- Assessing the indication for allergen-specific immunotherapy (AIT).
Main Results:
- Molecular diagnostics improve accuracy, especially in cases with ambiguous extract-based tests.
- Distinguishes between true dual sensitization and cross-reactivity to bee or wasp venom.
- Rush AIT shows particular effectiveness as an initial treatment strategy.
Conclusions:
- Modern diagnostics, including molecular testing, are crucial for accurate Hymenoptera venom allergy management.
- Allergen-specific immunotherapy (AIT), particularly rapid desensitization, offers an effective treatment approach.
Related Concept Videos
Allergic Reactions: Anaphylaxis
Allergic Reactions
Allergic Drug Reactions
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Upper Respiratory Drugs: First and Second-Generation Antihistamines
Histamine binds to specific receptor sites, known as H1 receptors, on tissue cells, triggering inflammation and swelling. Antihistamines combat these effects by competing with histamine for these receptor sites. By...
Drug Toxicity: Allergic Reactions

